Kaili Mao1, Cécile Badoual2, Philippe Camparo3,
Nicolas Barry Delongchamps1, Annick Vieillefond4,
Anh-Tuan Dinh-Xuan5, Michaël Peyromaure1
Canadian Journal of Urology, Vol.15, No.5, pp. 4257-4262, 2008
Abstract Objectives: To study the prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor VEGFR-1 in localized prostate cancer.
Methods: One hundred patients undergoing radical prostatectomy (RP) for clinically localized prostate cancer were prospectively included. Plasma levels of VEGF-A were measured preoperatively. After intervention, tissue microarrays were built from the RP specimens. VEGF-A and VEGFR-1 expressions in prostate cancer tissue were determined using immunochemistry. Then the associations between plasma levels of VEGF-A, VEGF-A and VEGFR-1 expressions in prostate cancer tissue, and the outcome of patients were analyzed.
Results: After a median follow-up of 22 months, 14 patients More >